Cargando…
Pathophysiology of Type 2 Diabetes in Children and Adolescents
Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysio...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516333/ https://www.ncbi.nlm.nih.gov/pubmed/29879890 http://dx.doi.org/10.2174/1573399814666180608074510 |
_version_ | 1783586985713074176 |
---|---|
author | Valaiyapathi, Badhma Gower, Barbara Ashraf, Ambika P. |
author_facet | Valaiyapathi, Badhma Gower, Barbara Ashraf, Ambika P. |
author_sort | Valaiyapathi, Badhma |
collection | PubMed |
description | Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysiology of type 2 DM in children and adolescents. Methods and Results: This is a comprehensive review of the literature on this topic. Type 2 DM in childhood is viewed as a continuum of insulin resistance (IR) which is determined by an underlying genetic predisposition, intrauterine environment, excessive food consumption, continued rapid weight gain, and poor lifestyle. Besides IR, this is compounded by multiple metabolic defects including β-cell dysfunction and inadequate insulin secretion, α-cell dysfunction, hyperglucagonemia and increased hepatic glucose production, lipotoxicity, inflammation, deficiencies in incretin production and action, and increased renal glucose reabsorption. The confluence of genetic and environmental factors underscores the complexity in disease progression. Conclusion: A consistent single risk factor for type 2 DM is obesity and related IR and therefore it is essential to curtail the progression of obesity. It is important to investigate the role of stringent dietary and nutritional approaches, medications that enhance β-cell function and insulin sensitivity. |
format | Online Article Text |
id | pubmed-7516333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-75163332020-10-15 Pathophysiology of Type 2 Diabetes in Children and Adolescents Valaiyapathi, Badhma Gower, Barbara Ashraf, Ambika P. Curr Diabetes Rev Diabetes Background: The prevalence of type 2 diabetes (DM) in children is disturbingly increasing in parallel with the increasing childhood obesity. Better knowledge regarding the pathophysiology of type 2 DM in children is paramount to devise an effective management plan. Objective: Discuss the pathophysiology of type 2 DM in children and adolescents. Methods and Results: This is a comprehensive review of the literature on this topic. Type 2 DM in childhood is viewed as a continuum of insulin resistance (IR) which is determined by an underlying genetic predisposition, intrauterine environment, excessive food consumption, continued rapid weight gain, and poor lifestyle. Besides IR, this is compounded by multiple metabolic defects including β-cell dysfunction and inadequate insulin secretion, α-cell dysfunction, hyperglucagonemia and increased hepatic glucose production, lipotoxicity, inflammation, deficiencies in incretin production and action, and increased renal glucose reabsorption. The confluence of genetic and environmental factors underscores the complexity in disease progression. Conclusion: A consistent single risk factor for type 2 DM is obesity and related IR and therefore it is essential to curtail the progression of obesity. It is important to investigate the role of stringent dietary and nutritional approaches, medications that enhance β-cell function and insulin sensitivity. Bentham Science Publishers 2020-04 2020-04 /pmc/articles/PMC7516333/ /pubmed/29879890 http://dx.doi.org/10.2174/1573399814666180608074510 Text en © 2020 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Diabetes Valaiyapathi, Badhma Gower, Barbara Ashraf, Ambika P. Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title | Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title_full | Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title_fullStr | Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title_full_unstemmed | Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title_short | Pathophysiology of Type 2 Diabetes in Children and Adolescents |
title_sort | pathophysiology of type 2 diabetes in children and adolescents |
topic | Diabetes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516333/ https://www.ncbi.nlm.nih.gov/pubmed/29879890 http://dx.doi.org/10.2174/1573399814666180608074510 |
work_keys_str_mv | AT valaiyapathibadhma pathophysiologyoftype2diabetesinchildrenandadolescents AT gowerbarbara pathophysiologyoftype2diabetesinchildrenandadolescents AT ashrafambikap pathophysiologyoftype2diabetesinchildrenandadolescents |